| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 76.001 | 0 | 0 | 60.731 | 1.264 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 78.459 | 1.782 | 1.303 | 61.755 | 1.645 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 10.212 | 7.147 | 3.545 | 42.223 | 25.685 | 127 | 95 | 97 | 0 | 0 |
| Gross Profit/Loss - EUR | 68.247 | -5.365 | -2.242 | 19.532 | -24.040 | -127 | -95 | -97 | 0 | 0 |
| Net Profit/Loss - EUR | 57.328 | -5.365 | -2.242 | 18.925 | -24.052 | -127 | -95 | -97 | 0 | 0 |
| Employees | 1 | 1 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Eurorx 2014 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 67.000 | 51.738 | 48.621 | 68.329 | 41.012 | 40.107 | 39.122 | 39.147 | 39.028 | 38.810 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 16.770 | 17.320 | 17.396 | 22.676 | 16.967 | 16.645 | 16.276 | 16.327 | 36.493 | 36.290 |
| Cash | 50.229 | 34.419 | 31.225 | 45.652 | 24.045 | 23.462 | 22.846 | 22.820 | 2.535 | 2.520 |
| Shareholders Funds | 57.373 | 51.422 | 48.310 | 66.349 | 41.012 | 40.107 | 39.122 | 39.147 | 39.028 | 38.810 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.650 | 316 | 311 | 1.980 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7490 - 7490" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Eurorx 2014 Srl